SCHEMBL4078807

SCHEMBL4078807

CC(CCCBr)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.47
TAAR1 Q96RJ0 4/20 0.47
SLC6A2 P23975 3/20 0.47
SLC6A4 P31645 2/20 0.47
SLC6A3 Q01959 2/20 0.47
MAOA P21397 1/20 0.47
CYP2A6 P11509 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA1 P30542 1/20 0.47
SLC18A2 Q05940 1/20 0.44
CYP2D6 P10635 1/20 0.44
TRPA1 O75762 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
HTR2A P28223 1/20 0.40
ADRA1A P35348 1/20 0.40
OPRK1 P41145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9177063 0.94 SIGMAR1 (0.45) SIGMAR1TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL9440812 0.84 PTGS1 (0.39) MEN1KMT2AHTR2AEPHX1
SCHEMBL6286870 0.82 SIGMAR1 (0.55) SIGMAR1TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL6824286 0.82 CSNK1E (0.49) SIGMAR1TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL7937685 0.82 TRPA1 (0.53) SIGMAR1TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL28296318 0.82 SIGMAR1 (0.48) SIGMAR1TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL14732887 0.80 SIGMAR1 (0.40) SIGMAR1TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL6693090 0.80 CSNK1E (0.56) SIGMAR1TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL9418115 0.80 SIGMAR1 (0.56) SIGMAR1
Water SCHEMBL28873017 0.80 SIGMAR1 (0.47) SIGMAR1TAAR1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038041-A2 THERAPEUTIC COMPOUNDS AND THEIR USE IN CANCER Myriad Genetics, Inc. (US) 2009-03-25 EP disclosed
WO-2007134298-A2 THERAPEUTIC COMPOUNDS AND THEIR USE IN CANCER MYRIAD GENETICS, INC. (US) 2007-11-22 WO disclosed